Increasing Lung Cancer Screening Virtual Forum
Thursday, November 10, 2022 12:00pm-2:30pm PST
This meeting was co-hosted by the American Cancer Society and California Dialogue on Cancer as part of our partnership to increase cancer screening rates among California’s diverse population. Given the high mortality rate from lung cancer and California’s lung cancer screening rates being among the lowest in the county, in 2022 we began focusing specifically on lung cancer screening. Thank you to all who were able to join us live, and please feel free to share the recording. .
Did you know?
- Lung cancer is the leading cause of cancer deaths in the U.S., killing more people than colon, breast and prostate cancers combined.
- Annual lung cancer screening with Low-Dose Computed Tomography (LDCT) is the only proven early detection procedure to reduce lung cancer mortality for individuals at high-risk for lung cancer.
- The five-year relative survival rate for lung cancer is 60% when diagnosed at a localized stage, however, only 24% of lung cancer cases are diagnosed early. 
- Screening offers the opportunity to increase survival rates, but screening rates remain low, with a national average rate of 5.7%. California is among the lowest in the nation for lung cancer screening, with an estimated screening rate of 1%. 
We can do better! Thank you for joining us on November 10th
We convened healthcare, public health, and community outreach professionals through this informative forum. During late 2022 and early 2023, the American Cancer Society and the California Dialogue on Cancer are in the process of collecting stakeholder input in order to determine the role we can play to best help move this work forward. Submit your input here.
Questions? Please reach out to us at email@example.com
American Cancer Society. Cancer Facts & Figures 2022. Atlanta: American Cancer Society; 2022 Facts and Figures 2022
American Lung Association, State of Lung Cancer, 2022 State Data | California | American Lung Association